Zymeworks Price to Book Ratio 2016-2022 | ZYME
Historical price to book ratio values for Zymeworks (ZYME) over the last 10 years. The current price to book ratio for Zymeworks as of February 03, 2023 is 2.46.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Zymeworks Price/Book Ratio Historical Data |
| Date |
Stock Price |
Book Value per Share |
Price to Book Ratio |
| 2023-02-03 |
9.48 |
|
2.46 |
| 2022-06-30 |
5.30 |
$3.85 |
1.38 |
| 2022-03-31 |
6.55 |
$4.89 |
1.34 |
| 2021-12-31 |
16.39 |
$5.34 |
3.07 |
| 2021-09-30 |
29.04 |
$5.99 |
4.85 |
| 2021-06-30 |
34.69 |
$6.95 |
4.99 |
| 2021-03-31 |
31.58 |
$8.17 |
3.87 |
| 2020-12-31 |
47.26 |
$8.90 |
5.31 |
| 2020-09-30 |
46.58 |
$9.44 |
4.93 |
| 2020-06-30 |
36.07 |
$10.78 |
3.35 |
| 2020-03-31 |
35.47 |
$11.47 |
3.09 |
| 2019-12-31 |
45.46 |
$6.21 |
7.32 |
| 2019-09-30 |
24.80 |
$7.87 |
3.15 |
| 2019-06-30 |
22.00 |
$8.53 |
2.58 |
| 2019-03-31 |
16.18 |
$5.30 |
3.05 |
| 2018-12-31 |
14.68 |
$5.64 |
2.60 |
| 2018-09-30 |
15.70 |
$5.31 |
2.96 |
| 2018-06-30 |
14.78 |
$5.84 |
2.53 |
| 2018-03-31 |
12.02 |
$3.71 |
3.24 |
| 2017-12-31 |
7.59 |
$4.58 |
1.66 |
| 2017-06-30 |
8.35 |
$3.83 |
2.18 |
| 2017-09-30 |
7.98 |
$3.26 |
2.45 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.597B |
$0.027B |
|
Zymeworks Inc. is a clinical-stage biopharmaceutical company. It engages in the discovery, development, and commercialization of bio-therapeutics for the treatment of cancer in Canada. The companys lead product candidate includes ZW25 and ZW33 which are in clinical trial stage. Zymeworks Inc. is headquartered in Vancouver, Canada.
|
